- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Biogen Idec Inc+ Add to Watchlist
BIIB:US329.450 USD 8.450 2.63%
As of 09:34:49 ET on 10/31/2014.
Company Profile for Biogen Idec Inc (BIIB)
Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
Biogen Idec Inc
Key Executives for Biogen Idec Inc (BIIB)
|George A ScangosChief Executive Officer||Susan H AlexanderExec VP/Chief Legal Ofcr/Secy|
|Paul J ClancyExec VP:Finance/CFO||Adriana Karaboutis "Andi"Exec VP:Tech & Bus Solutions|
|Alfred W Sandrock JrSenior VP/Chief Medical Ofcr||Spyros Artavanis-TsakonasSenior VP/Chief Scientific Ofcr|
|Gregory F CovinoVP:Finance/Chief Acctg Officer||Claudine ProwseVP:Investor Relations|